Our services and products are client-driven, and are inspired by our customers’ needs. The following list represents effective strategies that we have developed to meet our clients’ needs. We "bundled" products and services into modules, which have typically served clients as they venture into or expand their presence within the industry.
However, this list is ever-expanding, and is not limited to the following options. Your organization can, of course, use these modules and the products within them exactly as they stand, to great effect. But you can also “cherry-pick” the services and products that best meet your needs, or work with Leomics to develop new options that are tailored precisely to your company. This list is simply the starting line; Leomics will be with you every step of the way as you journey into personalized medicine.
MODULE 1: THE START UP SUCCESS TOOLKIT
This menu is designed to help small start-ups with new technologies or new tests develop a credible business plan. This toolkit employs analysis of a company’s technologies, IP and applications, and focuses on raising VC and Alliances capital.
Competitive landscape analysis of current and future competing products
Market analysis of technologies, scientific, medical and market trends
Assessment of current product and potential product portfolio, focusing on stage of technical, clinical and commercial development; probability of technical, clinical and commercial success; time to market; market analysis; and revenue forecasts
Selection of successful product applications pipeline, at discovery, development, or licensing levels
Maximization of the current business plan
Product development and R/D in analytical and clinical phases
Analysis of academic collaboration alliances
Analysis of commercial collaboration alliances
VC funding potential and valuation
Corporate funding possibilities
Identification and recruitment of key management or scientific/technical personnel, SAB, and Board of Directors
Raising company profile within both commercial and academic spaces
CLIA lab planning and formation
Regulatory approval and quality assurance
Pricing and reimbursement strategies
Procurement of clinical samples for product validation
MODULE 2: THE LEADERSHIP GROWTH PROGRAM
This menu is focuses on established diagnostic companies with either great expertise in the field of molecular diagnostics, or with strategic intentions to enter it. This program provides an in-depth market analysis, and assesses the most effective opportunities for product development, licensing, M&A, alliances and partnerships.
Analysis of current pipeline portfolio of products, technologies and business development deals, including probability of technical, clinical and commercial success; revenue and time-to-market forecasts; benchmarking against competing products and competitors pipelines; and customer perception surveys
Creation of market boosting strategies for existing and future products
Alliance formation with payers and leading Ivory Towers
Product cost-effectiveness studies
Selection and analysis of new potential organic product pipeline through lower-risk licensing; in-house R/D; and/or academic or industrial alliances
Future organic pipeline creation through cost-effective licensing on unique opportunities
Creation of profitability increase strategies through reimbursement improvement and clinical economics analysis
Implementation of novel high performance technologies
International market penetration to Latin America, South Asia, China, and Europe
Identification of unique mergers and acquisition opportunities
New market opportunity analysis, focusing on players, trends, customers, forecasts, costs, and risks
New product analysis, including companion diagnostics testing, anatomical pathology molecular testing, point of care, boutique esoteric testing, and personal spa testing
MODULE 3: INVESTOR OPPORTUNITY EVALUTATION
These services are for VCs or corporate organizations considering investing in companies with new products, technologies or services. Leomics scans the current and future market, as well as works closely with respected industry specialists, to provide realistic analysis and forecasts on revenues, valuation and risk.
Technology/Product assessment, focusing on IP, novelty, value, developmental and validation stage
Risk assessment, based on probability of technical, clinical and commercial success
Market analysis, based on market landscape, current and future competitors, pricing and profitability, revenue, and time-to-market forecast
Management and scientific personnel consulting
Comprehensive scoring index
Recommendations for risk mitigation
Guidance on leveraging product acceptance
MODULE 4: ENTERING THE SPACE: TRANSITIONING INTO THE LIFE SCIENCES/DIAGNOSTIC INDUSTRY
This highly relevant product was developed specifically to help traditionally non-diagnostic companies enter the industry, with special emphasis on laboratory services, in-vitro diagnostics, and diagnostic-focused product lines.
Analysis of current and future diagnostic markets, including players, products, market sizes, projections, trends and opportunities
Competitive analysis of life sciences companies’ existing product portfolios
Definition of optimal menu of products, including identification of new products
Development and validation strategies
Reimbursement and pricing strategies
Marketing and commercialization alliances
Customer identification and service
MODULE 5: THE ACADEMIC DIAGNOSTIC TESTING ENTERPRISE
New academic players are currently entering the commercial diagnostic space, creating many novel and successful services. Leomics offers scholarly institutions the guidance to develop a pipeline of commercial products that reflect academia’s high standards and ethics. This service analyzes the institution’s potential to adapt to the commercial innovation process, and helps to build the alliances necessary to fund the pipeline process.
Analysis of internal institutional capabilities, and guidance on leveraging these assets and how to leverage them in the context on an internal effort or an alliance enterprise
Product pipeline development, including validation and commercialization
Creation of industry alliances
MODULE 6: CLINIC ECONOMIC EVALUATION: THE NET-SAVINGS PRESENT VALUE (NSPV) WHITE PAPER
This service allows helps clients who are currently working with diagnostic testing or considering entering the space create an overall economic forecast for their organization.
Cost analysis for specific products within the context of overall disease management costs
Literature review, including application of test results within the context of clinical decision making and therapy response, outcomes, complications, quality of life, and overall survival
Definition and documentation of test value based on test-induced savings on costs related to hospitalization, drugs, additional diagnostic testing, medical procedures, intensive care, emergency room, and medical visits
Justification of test pricing
Analysis of current feedback from payers, physicians, and other health care providers